reports
Damartex: 1 director
A director at Damartex bought 150,000 shares at 2.800EUR and the significance rating of the trade was 93/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
Ipsos: Monthly declaration of shares and voting rights - November 2025
Ipsos: Monthly declaration of shares and voting rights - November 2025 December 19, 2025 MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Articles L. 233-8 II of the Commercial Code and 223-16 of the General Regulation of the AMF Date Shares Voting rightsTheoretical*Exercisable**30 November 202543,203,22548,976,32148,922,224 *This number is calculated on the basis of all the shares to which voting rights are attached, including shares which voting rights have been suspended, in accordance with Article 223-11 of the AMF general regulation related to the calculation of th...
Ipsos : Déclaration mensuelle d'actions et de droits de vote - Novembr...
Ipsos : Déclaration mensuelle d'actions et de droits de vote - Novembre 2025 19 décembre 2025 PUBLICATION MENSUELLE DU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL ET DU NOMBRE TOTAL DE DROITS DE VOTE Articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’AMF Date Nombre d’actions composant le capital Nombre total de droits de votethéoriques*exerçables**30 novembre 202543 203 22548 976 32148 922 224 * Ce nombre est calculé sur la base de l’ensemble des actions auxquelles sont attachés des droits de vote, y compris les actions privées de droit de vote, conformément à l’articl...
Guerbet: Appointment of Mr. François Convenant as Senior Vice Presiden...
Guerbet: Appointment of Mr. François Convenant as Senior Vice President of Interventional Radiology and his entry into the Executive Committee Guerbet announces the appointment of Mr. François Convenant as Senior Vice President of Interventional Radiology and his entry into the Executive Committee Villepinte, December 19, 2025: GUERBET (FR0000032526 GBT), a global player in medical imaging, announces the appointment of François Convenant as Senior Vice President of Interventional Radiology.In this role, he joins the Guerbet Group's Executive Committee (COMEX). This appointment marks an...
GUERBET: Nomination de M. François Convenant en tant que Senior Vice-P...
GUERBET: Nomination de M. François Convenant en tant que Senior Vice-Président Radiologie Interventionnelle et son entrée au Comité Exécutif Guerbet annonce la nomination de M. François Convenant en tant que Senior Vice-Président Radiologie Interventionnelle et son entrée au Comité Exécutif Villepinte, le 19 décembre 2025 : GUERBET (FR0000032526 GBT), acteur mondial de l’imagerie médicale, annonce la nomination de François Convenant au poste de Senior Vice-Président Radiologie Interventionnelle. À ce titre, il rejoint le Comité Exécutif (COMEX) du groupe Guerbet. Cette nomination mar...
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Ipsos SA and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 12 December 2025 in which we reassessed the appropriateness of the ratings in the context of the r...
Appointment of François Michel as Chief Executive Officer of the GTT G...
Appointment of François Michel as Chief Executive Officer of the GTT Group Appointment of François Michel as Chief Executive Officer of the GTT Group Paris, 15 December 2025 – The GTT Group announces the appointment of François Michel as Chief Executive Officer, effective 5 January 2026, thereby restoring a dissociated governance structure. This decision was taken unanimously by the Board of Directors of the Group at its meeting held on 13 December 2025. Following a demanding selection process, the Board of Directors selected François Michel for his managerial experience, his strong com...
Nomination de François Michel en qualité de Directeur général du group...
Nomination de François Michel en qualité de Directeur général du groupe GTT Nomination de François Michel en qualité de Directeur général du groupe GTT Paris, le 15 décembre 2025 – Le groupe GTT annonce la nomination de François Michel en qualité de Directeur général, à compter du 5 janvier 2026, et retrouve ainsi une gouvernance dissociée. Cette décision a été prise à l’unanimité par le Conseil d’administration du Groupe, réuni le 13 décembre 2025. À l’issue d’un processus de sélection exigeant, le Conseil d’administration a retenu la candidature de François Michel pour son expérience ...
- Carole Braudeau
- Carole Braudeau
Ipsos – Organizational change
Ipsos – Organizational change Ipsos – Organizational change Paris, 9 December 2025 - Dan Lévy, Group Chief Financial Officer of Ipsos, will shortly step down from his role and pursue new opportunities outside the Group. Ipsos thanks Dan for his contribution over the past three years and wishes him every success in his future endeavours. Olivier Champourlier, currently Head of Group Controlling at Ipsos, is assuming the role of Interim Chief Financial Officer, effective immediately. He has previously served as the Group Head of Consolidation, Accounting and Tax, and as Chief Financial Off...
Ipsos – Evolution de l’organisation
Ipsos – Evolution de l’organisation Ipsos – Evolution de l’organisation Paris, 9 décembre 2025 - Dan Lévy, Directeur Financier du Groupe , quittera prochainement ses fonctions et poursuivra de nouvelles opportunités à l’extérieur du Groupe. Ipsos remercie Dan pour sa contribution au cours des trois dernières années et lui souhaite beaucoup de succès dans ses futurs projets. Olivier Champourlier, actuellement Directeur du Contrôle de Gestion Groupe chez Ipsos, assume à effet immédiat le rôle de Directeur Financier par intérim. Il a précédemment été Directeur de la Consolidation, de la Co...
- Elias New
- Philip Hettich
GBT GUERBET SA
CDA COMPAGNIE DES ALPES SA
BOSS HUGO BOSS AG
A1XA4J CARBIOS SA
QDT QUADIENT SA
CAI CA IMMOBILIEN ANLAGEN AG
UBS UBM DEVELOPMENT AG
SLR SOLARIA ENERGIA Y MEDIO AMBIENTE S.A.
COPN COSMO PHARMACEUTICALS NV
M MED LIFE
WAVE WAVESTONE SA
LOUP SOCIETE L.D.C.
SHA SCHAEFFLER AG
- Elias New
- Philip Hettich
GBT GUERBET SA
CDA COMPAGNIE DES ALPES SA
BOSS HUGO BOSS AG
A1XA4J CARBIOS SA
QDT QUADIENT SA
CAI CA IMMOBILIEN ANLAGEN AG
UBS UBM DEVELOPMENT AG
SLR SOLARIA ENERGIA Y MEDIO AMBIENTE S.A.
COPN COSMO PHARMACEUTICALS NV
M MED LIFE
WAVE WAVESTONE SA
LOUP SOCIETE L.D.C.
SHA SCHAEFFLER AG
- Aurelien Sivignon
- Aurelien Sivignon
- Christophe-Raphaël Ganet
- Christophe-Raphaël Ganet
GUERBET : Adjustment of 2025 financial targets.
GUERBET : Adjustment of 2025 financial targets. Adjustment of 2025 financial targets Villepinte, 2 December 2025, 5.45 p.m.: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing a downward revision to its financial targets for full-year 2025. Following an inspection by the U.S. Food and Drug Administration (FDA) during the first half of the year, the Guerbet Group developed and initiated the implementation of a compliance plan at its Raleigh site in the United States. This plan has been reinforced over the past weeks in respo...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.